{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:51:59Z","timestamp":1782730319029,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["theclinics.com","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cld.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T14:21:17Z","timestamp":1425046877000},"page":"309-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Elevated Alpha-Fetoprotein"],"prefix":"10.1016","volume":"19","author":[{"given":"Robert J.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cld.2015.01.005_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cld.2015.01.005_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/CMO.S9926","article-title":"Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics","volume":"8","author":"Flores","year":"2014","journal-title":"Clin Med Insights Oncol"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/M14-0095","article-title":"The changing burden of hepatitis C virus infection in the United States: model \u2013based predictions","volume":"161","author":"Kabiri","year":"2014","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.cld.2015.01.005_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/lt.23551","article-title":"Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma","volume":"18","author":"Biggins","year":"2012","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2015.01.005_bib5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"issue":"35","key":"10.1016\/j.cld.2015.01.005_bib6","doi-asserted-by":"crossref","first-page":"12588","DOI":"10.3748\/wjg.v20.i35.12588","article-title":"Short-term interval chemoembolization and radiofrequency ablation for hepatocellular carcinoma","volume":"20","author":"Choe","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"29","key":"10.1016\/j.cld.2015.01.005_bib7","doi-asserted-by":"crossref","first-page":"10174","DOI":"10.3748\/wjg.v20.i29.10174","article-title":"Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis","volume":"20","author":"Dong","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1499-3872(14)60037-0","article-title":"Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis","volume":"13","author":"Xu","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0033-1351783","article-title":"Hepatocellular carcinoma: resection versus transplantation","volume":"33","author":"Earl","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2015.01.005_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cld.2011.03.008","article-title":"Conventional surgical treatment of hepatocellular carcinoma","volume":"15","author":"Earl","year":"2011","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2015.01.005_bib11","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1572-0241.2006.00443.x","article-title":"Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?","volume":"101","author":"Farinati","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.01.005_bib13","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1002\/hep.1840360711","article-title":"Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systemic review","volume":"36","author":"Gebo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/0003-4819-139-1-200307010-00012","article-title":"Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systemic review and critical analysis","volume":"139","author":"Gupta","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2015.01.005_bib15","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1053\/j.gastro.2004.09.023","article-title":"Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma","volume":"127","author":"Daniele","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.01.005_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.01.005_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1055-9965.EPI-11-1005","article-title":"Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"21","author":"Singal","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cld.2015.01.005_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1148\/radiol.2262011980","article-title":"Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET","volume":"226","author":"Teefey","year":"2003","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cld.2015.01.005_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0168-8278(99)80016-6","article-title":"Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis","volume":"30","author":"Kumada","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2015.01.005_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1872-034X.2007.00216.x","article-title":"Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan","volume":"38","author":"Makuuchi","year":"2008","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","article-title":"Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients","volume":"91","author":"Koike","year":"2001","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cld.2015.01.005_bib23","first-page":"249","article-title":"A\u00a0simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients","volume":"7","author":"Shimauchi","year":"2000","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.cld.2015.01.005_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1542-3565(05)00855-4","article-title":"Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma","volume":"4","author":"Toyoda","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.01.005_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-2007-3202","article-title":"Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3","volume":"3","author":"Volk","year":"2007","journal-title":"Cancer Biomark"},{"issue":"2","key":"10.1016\/j.cld.2015.01.005_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the study of the liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2015.01.005_bib27","series-title":"NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Version 2013","author":"National Comprehensive Cancer Network (NCCN)","year":"2013"},{"key":"10.1016\/j.cld.2015.01.005_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","article-title":"Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version","volume":"29","author":"Kudo","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2015.01.005_bib29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.01.005_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/153537020122600503","article-title":"Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants","volume":"226","author":"Mizejewski","year":"2001","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.cld.2015.01.005_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000072332","article-title":"AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients","volume":"65","author":"Adachi","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.cld.2015.01.005_bib32","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.3748\/wjg.15.5976","article-title":"Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma","volume":"15","author":"Shen","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2015.01.005_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0676.1986.tb00279.x","article-title":"Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma","volume":"6","author":"Liaw","year":"1986","journal-title":"Liver"},{"key":"10.1016\/j.cld.2015.01.005_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/jhep.2000.17914","article-title":"Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study","volume":"32","author":"McMahon","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status","volume":"34","author":"Trevisani","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.01.005_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/jhep.2002.34744","article-title":"Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis","volume":"36","author":"Nguyen","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1478-3231.2004.0903.x","article-title":"Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients","volume":"24","author":"Rapaccini","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.01.005_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/jms.6.2.108","article-title":"Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer","volume":"6","author":"Zhang","year":"1999","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.cld.2015.01.005_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01438313","article-title":"Prospective study of early detection for primary liver cancer","volume":"123","author":"Yang","year":"1997","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.cld.2015.01.005_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.cld.2015.01.005_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","article-title":"Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for early detection of hepatocellular carcinoma","volume":"138","author":"Lok","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2893.2007.00928.x","article-title":"Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C","volume":"15","author":"Bruce","year":"2008","journal-title":"J\u00a0Viral Hepat"},{"issue":"5","key":"10.1016\/j.cld.2015.01.005_bib44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2014.01.045","article-title":"A\u00a0new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis","volume":"146","author":"El-Serag","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.01.005_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-6143.2009.02750.x","article-title":"Progression of alpha-fetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor","volume":"10","author":"Vibert","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2015.01.005_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/lt.21999","article-title":"Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States","volume":"16","author":"Pomfret","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2015.01.005_bib47","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.22693","article-title":"Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database","volume":"49","author":"Toso","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib48","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","article-title":"Early recognition of hepatocellular carcinoma\u00a0based on altered profiles of alpha-fetoprotein","volume":"328","author":"Sato","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2015.01.005_bib49","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840220317","article-title":"A\u00a0clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients","volume":"22","author":"Shiraki","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0168-8278(96)80069-9","article-title":"Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma","volume":"25","author":"Wang","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.01.005_bib51","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/j.1572-0241.2007.01405.x","article-title":"Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis","volume":"102","author":"Sterling","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2015.01.005_bib52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1478-3231.2010.02348.x","article-title":"Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-gamma-carboxyprothrombin","volume":"31","author":"Inagaki","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.01.005_bib53","first-page":"1036","article-title":"Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group","volume":"95","author":"Ishii","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.01.005_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.01.005_bib55","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/j.1572-0241.2006.00681.x","article-title":"Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma varies according to tumor size","volume":"101","author":"Nakamura","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2015.01.005_bib56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bpg.2014.07.018","article-title":"Hepatocellular carcinoma tumour markers: current role and expectations","volume":"28","author":"Rich","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2015.01.005_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1572-0241.2006.00467.x","article-title":"Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review","volume":"101","author":"Colli","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2015.01.005_bib58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.cld.2015.01.005_bib59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2036.2012.05060.x","article-title":"Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma","volume":"35","author":"Hakeem","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.01.005_bib60","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1373\/49.5.752","article-title":"Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes","volume":"49","author":"Poon","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.cld.2015.01.005_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.20505","article-title":"Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases","volume":"41","author":"Paradis","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib62","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.20577","article-title":"SELDI-TOF MS profiling of serum for detection in the progression of chronic hepatitis C to hepatocellular carcinoma","volume":"41","author":"Schwegler","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.01.005_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/1078-0432.CCR-07-0586","article-title":"Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease","volume":"14","author":"Zinkin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cld.2015.01.005_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1349-7006.2003.tb01430.x","article-title":"Glypican-3 is overexpressed in human hepatocellular carcinoma","volume":"94","author":"Sung","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cld.2015.01.005_bib65","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/gut.48.4.558","article-title":"Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders","volume":"48","author":"Zhu","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cld.2015.01.005_bib66","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cld.2015.01.005_bib67","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-03-2191","article-title":"Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma","volume":"64","author":"Hippo","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cld.2015.01.005_bib68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-291X(03)00908-2","article-title":"Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker","volume":"306","author":"Nakatsura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cld.2015.01.005_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.01.005_bib70","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.3748\/wjg.v16.i35.4410","article-title":"Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma","volume":"16","author":"Liu","year":"2010","journal-title":"World J Gastroenterol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T13:33:17Z","timestamp":1717767197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1089326115000069"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.01.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Alpha-Fetoprotein","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}